ACE and angioedema: Hence, the concomitant selective blockade of Ang II receptors with an ARB prevents the potential effect of excess Ang II, whereas combining an NEP inhibitor with an ACE-i has been shown to cause unacceptably high rates of angioedema since both NEP and ACE contribute to breakdown of bradykinin (Packer et al., 2002).